Application Sponsors
ANDA 091493 | SAGENT PHARMS INC | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/5ML | 0 | ZOLEDRONIC ACID | ZOLEDRONIC ACID |
FDA Submissions
| ORIG | 1 | AP | 2014-11-24 | |
LABELING; Labeling | SUPPL | 4 | AP | 2015-09-03 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-12-21 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2020-12-21 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2020-12-21 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2020-12-21 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 17 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 7 | Null | 7 |
SUPPL | 8 | Null | 15 |
TE Codes
CDER Filings
SAGENT PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91493
[companyName] => SAGENT PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"ZOLEDRONIC ACID","activeIngredients":"ZOLEDRONIC ACID","strength":"EQ 4MG BASE\/5ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ZOLEDRONIC ACID","submission":"ZOLEDRONIC ACID","actionType":"EQ 4MG BASE\/5ML","submissionClassification":"INJECTABLE;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)